Objective: To investigate the clinical characteristics of 8 immunodeficiency cases caused by human recombination activating gene 1 (RAG1) mutations, and to explore the relationship among genotypes, clinical manifestations and immunophenotypes. Methods: Clinical data were collected and analyzed from patients with RAG1 mutations who visited the Department of Clinical Immunology, Children's Hospital of Fudan University between October 2013 and June 2017. The data included clinical manifestations, immunophenotypes and genotypes. Results: A total of 8 patients were diagnosed with RAG1 deficiency (6 boys and 2 girls). The minimum age of onset was 2 months, and the maximum age was 4 months. The minimum age of diagnosis was 2 months, and the maximum age was 13 years. Four patients had a family history of infant death due to severe infections. Two cases were born to the same consanguineous parents. All cases had recurrent infections, including involvement of respiratory tract (8 cases), digestive tract (6 cases), urinary tract (1 case), and central nervous system (1 case). The pathogens of infection included bacteria, viruses and fungi. Rotavirus was found in 3 cases, cytomegalovirus (CMV) in 5 cases, bacillus Calmette-Guérin adverse reaction in 2 cases (1 of whom had a positive acid-fast smear from lymph node puncture fluid), fungal infection in 3 cases. One case had multiple nodular space-occupying lesions in lungs and abdominal cavity complicated with multiple bone destruction. The peripheral blood lymphocyte counts of all patients ranged between 0.1 ×10(9)/L and 3.3×10(9)/L (median, 0.65×10(9)/L). Eosinophilia was found in 3 cases (range, (0.48-1.69) ×10(9)/L). The patients were classified according to immunophenotype as severe combined immunodeficiency phenotype (4 cases), leaky severe combined immunodeficiency (2 cases), Omenn syndrome (1 case) and combined immunodeficiency (1 case) . Decreased serum IgG levels were found in 3 cases, increased serum IgM levels in 3 cases, increased serum IgE levels in 5 cases. RAG1 homozygous mutations were detected in 5 cases and RAG1 compound heterozygous mutations in 3 cases. Two novel mutations and six previously reported mutations were identified. Three cases were successfully treated with hematopoietic stem cell transplantation. Four cases died due to infections, and the 13 year-old patient was still under follow-up in the outpatient clinic. Conclusions: Different RAG1 gene mutations can lead to diverse clinical presentations and immune phenotypes. Clinicians should pay attention to the family history of infant death with severe infection. In that situation, immunological evaluation and gene detection should be performed as early as possible.
目的: 总结人重组激活基因1(RAG1)突变所致免疫缺陷病的临床特征,探讨不同基因突变类型和临床、免疫表型间的关系。 方法: 回顾性病例总结。收集2013年10月至2017年6月,在复旦大学附属儿科医院临床免疫科就诊,经临床、免疫评估及基因分析确诊为RAG1基因突变患儿的临床资料,总结临床特征、免疫表型及基因分析结果。 结果: 8例患儿确诊为RAG1基因突变,男6例,女2例,起病年龄2~4月龄,诊断年龄2月龄~13岁。4例家庭有婴幼儿反复感染夭折的家族史。2例来自于同一个家庭,其父母为近亲婚配。所有病例均有反复感染,呼吸道(8例)和消化道感染(6例)最多见,其他系统感染包括泌尿道(1例)、中枢神经系统(1例)。感染病原包括细菌、病毒、真菌。轮状病毒感染3例;巨细胞病毒感染5例;卡介苗接种后不良反应2例,其中1例淋巴结穿刺液涂片抗酸染色阳性;真菌感染3例。1例发生肺部、腹腔多处结节性占位伴多发骨质破坏。8例外周血淋巴细胞计数(0.1~3.3)×10(9)/L(中位数0.65×10(9)/L),有3例嗜酸性粒细胞计数增高[(0.48~1.69) ×10(9)/L]。临床表型方面:4例为严重联合免疫缺陷病(SCID),2例为泄漏型SCID,1例为Ommen综合征,1例为联合免疫缺陷病。3例血清IgG低于正常范围,3例血清IgM高于正常范围,5例血清IgE增高。5例为RAG1基因纯合突变,3例为RAG1基因复合杂合突变,6例为已报道突变位点,2例为新发突变位点。3例行造血干细胞移植,4例死亡,1例门诊随访。 结论: RAG1基因不同突变方式导致临床表现多样,临床医生应重视家族史,对于存在婴儿期感染夭折的家庭尽早对患儿进行免疫功能评价和基因检测,尽早明确诊断和采取有效治疗。.
Keywords: Genes; Immunophenotyping; Severe combined immunodeficiency.